Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I am just hoping that reality catches up with this stock eventually. If they keep making money and we get a good energy bill passed, there could be a nice payday for all of us who are long.
More good news: Posted on Tuesday, 04.20.10
Industrial Nanotech, Inc. Approved As US Department of Energy (DOE) “Save Energy Now” ALLY Organization
NAPLES, Fla. -- Industrial Nanotech, Inc. (Pink Sheets:INTK), an emerging global leader in nanoscience energy saving solutions, today announced that the Company has been approved as a member of the U.S. Department of Energy’s (DOE’s) Industrial Technologies Program Save Energy Now as an ALLY organization. Save Energy Now is a national initiative that aims to drive a reduction of 25% or more in industrial energy intensity in 10 years. To achieve this ambitious goal, DOE’s Industrial Technologies Program is partnering with Save Energy Now LEADER Companies and Save Energy Now ALLY Organizations.
“For many years, we have worked closely with manufacturers to assist them in reducing energy costs on a daily basis,” explained Francesca Crolley, V.P. Business Development for Industrial Nanotech, Inc. “As a member of the Save Energy Now ALLY program, we can offer these manufacturers more tools and assistance from the U.S. Department of Energy’s Industrial Technology Program to help them meet their goals of reduced costs and increased efficiency. We can support the goals of reduction of 25% or more industrial energy intensity by assessing areas in factories and facilities where our nanotechnology based Nansulate® coatings can be used to insulate steam pipes, boilers, building envelope, roofs, and other areas. Nansulate® reduces energy used for heating and cooling as well as for heat processes used in manufacturing. Our technology has a well documented and proven track record of reducing energy costs in factories by 10% to 20% or more, and we look forward to helping more companies achieve those savings and become Save Energy Now LEADER companies. Reducing energy consumption across the nation is vital to our future, and we are proud to be working with the U.S. Department of Energy to achieve these goals through the Save Energy Now program.”
In 2008, manufacturing client Henateks, a textile manufacturer for Nike, Adidas and other apparel companies, used Nansulate® insulation coatings throughout their plant on heat exchangers, dye machines, steam boilers and other heat process equipment, and documented reduced energy savings of 20% due to use of the coatings. This equated to a savings of over $460,000 USD and reduced liquid natural gas (LNG) consumption by 1,980,943 m3. Their payback period was less than one year.
For more information on DOE’s efforts to reduce industrial energy intensity, visit the Save Energy Now Web site at: http://www1.eere.energy.gov/industry/saveenergynow/.
About Nansulate(R)
Nansulate(R) is the Company's patented product line of award winning, specialty coatings containing a nanotechnology based material and which are well-documented to provide the combined performance qualities of thermal insulation, corrosion prevention, resistance to mold growth, fire resistance, chemical resistance and lead encapsulation in an environmentally safe, water-based, coating formulation. The Nansulate(R) Product Line includes industrial, residential, agricultural and solar thermal insulation coatings. Additional information about the Company and its products can be found at their websites, (www.industrial-nanotech.com) and (www.nansulate.com). Blog: www.nansulate.com/nanoblog, Twitter: www.twitter.com/NanoPioneer. Search 'Nansulate' on Facebook.
Read more: http://www.miamiherald.com/2010/04/20/1588153/industrial-nanotech-inc-approved.html#ixzz0lenHRLjD
More good news...
--------------------------- (OTCBB: LWLL - Linkwell Corp.) LATEST NEWS!! Linkwell Corporation Announces Full Year 2009 Financial Results Revenues Grow 22.4%, With Net Income Growing 87.8% to $3 Million, or $.04 EPS SHANGHAI, April 19, 2010 -- Linkwell Corporation (OTC Bulletin Board: LWLL), a leading developer, manufacturer and distributor of healthcare related disinfectants in China, recently reported its financial results for the fiscal year ended December 31, 2009.
"We are very proud to deliver one of the best year end financial results in Linkwell's recent history," commented by Mr. Xuelian Bian, Chairman & CEO of Linkwell Corp., "Despite one of the worst financial crises in our recent memory; Linkwell management team continues to execute our long term growth plan very effectively and efficiently in 2009. We have dramatically improved our product quality and manufacturing capability. In 2010, we aim to allocate more resources on research and development of new products, as well as strengthen our marketing efforts. Our goal is to maintain and increase Linkwell's leadership position in Chinese hospital disinfectants industry, while expanding into other high growth and high margin segment of disinfectants market, such as consumer and other commercial usage markets." Mr. Bian concluded, "we also want to thank our shareholders for their confidence in our management team, and their long term support in the past few years. We are very confident that we will build long term shareholder value by leveraging our strength in Chinese healthcare disinfectant industry, and articulating our growth story to more new and existing investors." About Linkwell Corporation Linkwell Corporation, through its subsidiary, Linkwell Tech Group, Inc., develops, manufactures and distributes disinfectant healthcare products in China. Linkwell's disinfectant healthcare products are recognized as one of leading domestic Chinese brands in this market segment. Linkwell currently has 56 different products include disinfectants in liquid, tablet, powder and aerosol form. Linkwell has a national marketing and sales presence throughout all 22 provinces, 5 autonomous regions, and 4 special municipalities of China.
For more information, please visit http://www.linkwell.us .
Looks like the only responce I got from my little weekend Fantasy Investor game was... {and the winner is} Wellcrown!!!!
Latest News Releases
SOURCE: Universal Detection Technology
Apr 19, 2010 05:00 ETUniversal Detection Technology Expands Partnership With Wellcrown International; Offers Equipment for Sale in China
UNDT to Market Its Biological Weapon Detection Equipment in China
LOS ANGELES, CA--(Marketwire - April 19, 2010) - Universal Detection Technology (www.udetection.com) (OTCBB: UNDT), a developer of early-warning monitoring technologies and counter-terrorism training programs to protect people from bioterrorism and other infectious health threats and provider of counter-terrorism consulting and training services, reported today that it has expanded its partnership with Wellcrown International Resources, a leading marketer of defense and security solutions, by offering its biological weapon detection equipment for sale in China. UNDT had previously engaged Wellcrown for marketing its products in Malaysia.
Wellcrown International Resources Limited (www.wellcrowninternational.com) is a leading international supplier of sophisticated defense and security solutions and high-grade natural resources, as well as a diverse range of integrated services. The company is managed by a team of professionals with vast product knowledge and extensive service experience in relevant fields.
Universal Detection Technology's biological weapon detection equipment is used extensively by first responders and private industry throughout the country. The equipment, including UNDT's 5 agent biodetection kit certified by the U.S. Department of Homeland Security has been evaluated by the U.S. DoD as well as the United Kingdom military. UNDT also supplied its biological and radiation detection equipment for the protection of sports venues at the 2009 Olympics in Beijing.
"The expansion of our distribution agreement with Wellcrown will allow us to market our products through a partner with well established connections with the first responder community in China," said Jacques Tizabi, CEO of Universal Detection Technology.
For more information, please visit www.udetection.com or email info@udetection.com.
About Universal Detection Technology
Universal Detection Technology is a developer of monitoring technologies, including bioterrorism detection devices. The company on its own and with development partners is positioned to capitalize on opportunities related to Homeland Security. For example, the company, in cooperation with NASA, has developed a bacterial spore detector that detects certain biohazard substances. The company is also a reseller of handheld assays used for detection of five bioterrorism agents, radiation detection systems, and antimicrobial products. For more information, please visit www.udetection.com.
What is to happen to the "several acquisitions of gold mines".
The following is from the SEC post above.
[Hunt Gold President Michael Saner of Johannesburg, South Africa, said in a phone interview that his company had acquired Prime Time around 18 months ago through a reverse merger. Hunt Gold has announced several acquisitions of gold mines in recent months, but Saner said those were legitimate.
“These allegations have nothing to do with the incumbent board whatsoever. But the allegations have basically destroyed the company now,” Saner said.]
Thanx joker. It looks like we had the same ideas about getting involved with this company. Once the SEC does finish with them, do you think there is any chance that something could be left? If they do have possibly just a little gold left in them there hills to look for or sell after the smoke clears then .0001 could more than wiggle?
It's the weekend, so let's have some fun thinking about UNDT. This is a bit like Fantasy League Baseball for investors. To really take the company to the next level in a big way and take advantage of the niche they are carving out, especially considering the latest partnership for the Chameleon and the rest of it. They need a new and different kind of partner. One large enough and positioned in the home land security industry best to be able to take maximum advantage the intellectual property. Here is the Fantasy part. Of all the companies out there, who would be your pick to make the best match as a partner with UNDT for ultimate success? Maybe you are thinking of a company that is not even in the home land security game. Who can come up with the best pick???
Nope. I am not afilliated. Just a buyer as she goes down and a long term holder. The fuse may burn slowly and the little pops may temp selling but building a large long position on the dips is what I am doing. As for the news I am just passing it along to the board. Good luck to all.
The word is leaking out. Big day today???
Articles
Featured Profiles
Newsletters
Categorized | Newsletters
UNDT Major Update "Bottom Reversal Play"
Posted on 15 April 2010 by admin
First Alert: UNDT Major Update “Bottom Reversal Play”
I put my money where my profiles are….looking for a penny play not a double zero play.
I have been a buyer at these depressed prices. I am buying looking for major news and a my share price target over a penny short term (100% gain). The company is building looking for an upbeat future. I am expecting major news to explode with movement over the next ten days. Buying bottoms selling tops is the best way to approach a stock play such as UNDT. We all need to hold a position in anticipation of news
My skin is in my friend. I am just wondering who among us has used the product.
LWLL is the next Chinese Johnson &Johnson.
If anyone here has used this product please come forward and testify.
If anything at all comes of it, that is a foothold. If something substantial rusults, it's a mega banger.
If it goes lower, I will just have to buy another truck to back up. The old one is full.
I thought I may have seen somewhere that they were settling that or could that have been a nice daydrean of mine?
Did management say why it's "abandoned" HGLC? Could you give me a link to that if you can? Thanx
Let's all put todays news in our pipes and smoak it. Gives me a nice buzzzzzz.
Naples, Fla. (PRWEB) April 15, 2010 -- Industrial Nanotech, Inc. (Pink Sheets:INTK), an emerging global leader in nanoscience energy saving solutions, reported today that the Company's Nansulate® thermal insulation and corrosion resistant coatings provides effective insulation and protection for biofuel companies looking for insulation for fuel tanks and piping. Nansulate® Translucent PT and High Heat have been used at Michigan Biodiesel in Bangor Michigan, by Jatro Diesel, and at a new Fruitland Park, Florida facility by Smart Fuels, LLC. The coatings have also been highlighted this year with an article in Ethanol Producer magazine explaining the benefits the coatings provide for energy savings and asset protection.
"The Smart Fuels application is an excellent example of how Nansulate industrial coatings provide multiple solutions for these types of facilities.” stated Francesca Crolley, V.P. Business Development for Industrial Nanotech, Inc. “Smart Fuels chose Nansulate Translucent PT coating to insulate and protect new fuel storage tanks being installed at their facility in Fruitland Park, Florida. Nansulate High Heat was also applied to facility steam lines to reduce heat loss and corrosion. They chose our unique, patented technology for its ease of installation and ability to insulate more effectively and over a longer period of time than other types of insulation. It also provided the added benefits of protection against corrosion and resistance to moisture. The Biofuel industry is continuing to grow as the world continues to look for alternatives to petroleum based fuels and our coatings fit perfectly with their focus on green and sustainable solutions.”
Further information on Nansulate® for use on tanks and piping can be found at: http://www.nansulate.com/pipe_and_tank_insulation.htm. The feature in Ethanol Producer magazine and other news articles can be found at: http://www.nansulate.com/nansulate_news.htm.
Smart Fuels, LLC is a leading alternative energy company headquartered in Boston, that refines bio-diesel and related co-products from a variety of feedstocks, such as animal-derived fats and vegetable-based oils. Smart Fuels LLC is a voting member of the National Biodiesel Board.
Michigan BioDiesel LLC was formed with the combination of fifty-seven farmers and eight biodiesel distributors and other related business including technology provider, Jatro Diesel, to produce and market B100 through distributors. Michigan BioDiesel LLC markets biodiesel to customers through its distributors to many industries including on-highway fleets, maritime, military, home heating and agriculture industries.
My bad. Sorry. Thanks for clearing that up.
So if one recovers should we expect the other to improve? Thanks for you help. Is there hope for HGLC?
More good news yesterday: From:
Ken Thorpe Joins Linkwell Health Advisory Board
on April 14, 2010
Share this Article on Twitter
View Original Article on PR Newswire
Topics:Linkwell Corp (US OTC:LWLL)
NEEDHAM, Mass., April 14 /PRNewswire/ -- Today, Linkwell Health announced that it has further expanded its Advisory Board to include Ken Thorpe, Ph.D., Robert W. Woodruff Professor and Chair of the Depa
Could someone help me out here? Is FFGO and HGLC the same company?
Could someone help me out here? Is FFGO and HGLC the same company?
This is big...
Bioheart Commenced Successful Regenerative Stem Cell Treatments with Latin American Patients Having Congestive Heart Failure
SUNRISE, Fla., April 14 /PRNewswire-FirstCall/ -- Bioheart, Inc. (OTC Bulletin Board: BHRT) announced that treatment with stem cell therapy on two congestive heart failure (CHF) patients was performed successfully at the Hospital Angeles Tijuana, Mexico, through Bioheart's Center of Excellence program with Regenerative Medicine Institute.
The therapy employed stem cells derived from the patient's own fat (adipose tissue) obtained using liposuction. Stem cells were separated from the adipose tissue utilizing the fully-automated TGI 1200 Cell Isolation System. The separation process takes about an hour. No tissue pre-processing is required with this system. The recovered stem cells were injected into the patients' hearts utilizing Bioheart's MyoCath® needle injection catheter.
Dr. Karl Groth, Bioheart's Chairman and Chief Executive Officer explained, "These procedures validate Bioheart's innovation of effective treatments for the most serious cardiac health issues confronting people around the world. Our mandate is to bring Bioheart's solutions wherever they are needed and can be utilized."
These first two Latin American patients and other patients treated in Tijuana with Bioheart's cell therapies through Regenerative Medicine Institute will be followed at intervals of three and six months, and then a year, to assess their progress. The principal endpoint will be improvement in the six minute walk distance, a key measure for cardiac well being. Also measured will be improvement in the heart's viability, strength, and ability to function. The key to reversing the impact of heart disease is reduction in scar tissue. The therapy encourages the regeneration of heart muscle tissue, allowing new vibrant tissue to grow and enabling the pumping of blood by the heart to improve. The new tissue integrates into the scarred areas that are inactive, causing activity. Stem cells and myoblasts, which are muscle stem cells, are the bases for Bioheart's therapies.
In March, Bioheart entered into the first of its five planned agreements in Latin America to establish Centers of Excellence for the introduction of its therapies. The Regenerative Medicine Institute of Tijuana, Mexico is the first of these programs and provides therapies for congestive heart failure and peripheral arterial disease (PAD) patients at the Hospital Angeles Tijuana, a fully equipped state-of–the-art private specialties hospital.
Dr. Warren Sherman of Columbia University Medical Center's Stem Cell Research Institute was present at the procedures and assisted with the technology transfer. He, along with Dr. Christopher O'Conner, and Dr. Thomas Povsic, MD, PhD, of Duke University's Clinical Research Institute, have, with Bioheart, established an Academic Advisory Committee to monitor Bioheart's Centers of Excellence and gather data on the results seen by each Center. These results will, over time, become a compendium and form a nexus for future cell therapy research.
About Bioheart's program enabling treatment to be conducted in Centers outside the US, Dr. Sherman says, "I have come to believe that valuable knowledge can be gained from small-to-moderate sized clinical studies conducted outside of the US. Depending on objectives and design, the costs and logistics of certain studies can be burdensome, or even prohibitive to conduct in the US. The two key points here are, first and foremost, to ensure the rights and safety of patients, wherever a clinical trial is done. And secondly, that data arising from the study be complete and transparent. Without both elements in-place, a study will unlikely add to our knowledge of stem cell repair, or advance the field. To my eyes, Bioheart's initiative ensures that the integrity of both treatment and data collection is preserved, and I anticipate the scientific community will eagerly follow the program's progress."
Recent studies have identified adipose tissue as an alternate source of stem cells. The procedure for obtaining adipose derived stem cells from the patient is a relatively simple process and tolerated by most patients even immediately following a heart attack. Fat tissue can usually be found in abundance within the patient's own body and has a greater number of stem cells than bone marrow. The TGI 1200 Cell Isolation System can isolate stem cells in about an hour, allowing for immediate clinical, point-of-care treatment after an event like a heart attack, which is important to the effectiveness of the treatment. In contrast, the procedure for obtaining stem cells from bone marrow can be painful and often yields a low volume of stem cells.
Anton Krucky, CEO of Tissue Genesis, commented on Bioheart's successes with the use of the TGI system: "We are excited about the momentum that Bioheart is gaining in the use of Tissue Genesis' methods and technologies. Their recent successes in Europe and South America give us a great deal of confidence in Bioheart's ability to deliver cardiovascular regenerative medicine services to the Americas."
In addition to offering treatment for congestive heart failure with the TGI system, the Regenerative Medicine Institute will be using the system to treat lower limb ischemia using a similar process. The TGI 1200 Cell Isolation System is currently being utilized in clinical studies to treat chronic heart ischemia in Venezuela and critical limb ischemia in the Czech Republic.
Dr. Javier Lopez, Regenerative Medicine Institute's President, stated: "It is valuable to be able to help those in our country who are suffering from congestive heart failure and other cardiovascular problems that can be resolved with Bioheart's therapies and enables our Institute to be in the forefront of treatment centers around the world."
The final step for incorporating Bioheart therapies into its program will be adding MyoCell®, Bioheart's muscle stem cell therapy for CHF. MyoCell® is a clinical muscle-derived cell therapy designed to populate regions of scar tissue within a patient's heart with new living cells for the purpose of improving cardiac function in chronic heart failure patients.
About the TGI 1200 Cell Isolation System
The CE-marked TGI 1200 Cell Isolation System is a fully automated and simple system, which processes liposuctioned fat tissue and delivers isolated regenerative cells in about an hour. The compact desktop unit requires no tissue pre-processing, and fits easily into any clinical environment. The instrument allows for point-of-care recovery of an average of 50 million regenerative cells per 60cc of a patient's processed fat. These cells can then be used at the site of injury or disease. Regenerative cells may amplify the body's own repair process, accelerate healing, repair damaged and diseased tissue, and prevent scarring and loss of function.
About Heart Failure
Heart failure is a debilitating condition. When heart failure is in an advanced state, the heart is unable to pump enough blood to the body to allow a person to enjoy a normal, productive life. This disease affects over 5 million people in the United States. Over 500,000 new cases are diagnosed annually in the U.S., making heart failure the most rapidly growing of all cardiovascular disorders. According to statistics provided by the American Heart Association, the approximate direct and indirect annual cost of heart failure treatment in the U.S. is $22.5 billion. Persons over the age of 65 experience heart failure as the number one cause of hospitalization and the number one cause of death.
About Bioheart, Inc
Bioheart is committed to maintaining a leading position within the cardiovascular sector of the cell technology industry delivering cell therapies, intelligent devices and biologics that help address congestive heart failure, lower limb ischemia, chronic heart ischemia, acute myocardial infarctions and other issues. The Company works to prevent the worsening of any condition employing devices that monitor and diagnose. Bioheart's expertise is regenerating damaged tissue, if possible, and improving a patient's quality of life in addition to reducing health care costs and hospitalizations.
Specific to biotechnology, the Company is focused on the discovery, development and commercialization of autologous cell therapies for the treatment of chronic and acute heart damage and peripheral vascular disease, subject to regulatory approval. MyoCell, the Company's principal therapy, is a clinical muscle-derived cell therapy designed to populate regions of scar tissue within a patient's heart with new living cells for the purpose of improving cardiac function in chronic heart failure patients.
For more information on Bioheart, visit www.bioheartinc.com.
A quick question for the sages of 'The Question and Answer Board':
Is LWLL undervalued?
Ockham's Rating/Recommendation Summary
Buy Now LWLL
Revenue
Cash earnings is the most important factor in our analysis, but it goes without saying that if a company cannot produce sales then there is no ability to generate cash flow. By that logic we look very closely at revenue numbers as our second most important factor in valuing a company's stock. We have established reasonable Price to Sales per share ranges based on historical data of the last 9 years. For, LWLL the high and low end of the Price to Sales per share ratios are 17.49x and 1.32x respectively.
Notice that LWLL's current Price to Sales per share ratio is 0.71x, which is quite a bit below what we consider a normal Price to Sales ratio for this stock. Given normal conditions and a price of $0.12, LWLL is 93% below where we would expect to see it. This will beneficially factor into our final analysis of LWLL as it is not often that this stock sinks to these levels.
LWLL Cash Earnings
Cash Earnings is always one of the most important factors to review for a company and, more importantly, an investment in a stock. LWLL is significantly below its historical average multiple of cash earnings as calculated by Ockham. Similar to our analysis of sales per share, Ockham looks at the last 6 years of cash earnings levels for LWLL to identify where the current high and low price levels have been historically in relation to profit per share. Again, we utilize a weighted average methodology which relies more heavily on recent years of data. This weighted average framework provides us with an average high Price to Cash Earnings ratio per share of 29.36 and a 5.68 low over the same period.
Now that LWLL’s current price is $0.12 and its Price to Cash Earnings ratio is 3.00, we are very positive on its outlook from the cash earnings perspective. In fact, LWLL is now trading a full 83% below its average historical Price to Cash Earnings ratio at these profit per share levels. When our clients ask us why LWLL has great long term potential, the Cash Earnings levels to current stock is one of our primary reasons. But naturally, now we need for the overall market to recognize this disparity.
Nice dip today. How low can we go? Back up the truck brother. I am looking at this dip as a major buying opportunity, building my position in steady increments all the way down to the whatever the bottom may be, then selling enough to cover my cost on the next nice bounce (x3 or x4) and holding the shares bought with the houses money long term for the mega ring of the cash register. Not an investment strategy for the faint of heart. Good luck to all.
Who can tell me something good about this company?
I found this on the INTK facebook page. Good use of non traditional marketing and GOOD NEWS AGAIN!!!
Francesca Crolley sent a message to the members of Nansulate NanoPioneers.
Francesca CrolleyApril 13, 2010 at 5:49am
Subject: Press Release from Industrial Nanotech - Nansulate Use in Biofuel Industry
Happy Tuesday NanoPioneers!
Industrial Nanotech has a new press release out today regarding Nansulate's use in the Biofuel Industry. Click here to read more: http://www.facebook.com/l/302be;www.businesswire.com/news/home/20100413005915/en/Biofuel-Industry-Recognizes-Energy-Saving-Asset-Protection
BUT THAT'S NOT ALL.....
A new article is just out yesterday in the April/May issue of Alt Energy Mag, about how NanoPioneers are becoming the new Environmentalists. You can read it here: http://www.facebook.com/l/302be;www.altenergymag.com/emagazine.php?art_id=1494
Thanks for sharing our news on you social networking sites.
Have a wonderful day.
Best regards,
Francesca Crolley
NanoPioneer Team
Good job keeping the undt board about undt.
PSL does from time to time feature winners. UNDT will eventually be one. They are developing a niche in the national security market that is virtually vacant now and will unfortunately be call on in a big way at some point. It may not be an easy stock to own but if we hang in there buying the dips, the long term potential could make for nice paydays ahead.
Here is some info from PSL. Just passing it on. Still like the long term.
Dear PSL members,
Watch List: Universal Detection Technology (OTC:UNDT)
Universal Detection Technology (OTC:UNDT) last closed on $0.0038 with the trading volume of 38.61 million as on April 9th, 2010. The share has a negative beta of 0.03 times and maintains inverse correlation with market index. Total shares outstanding amounts to 959.89 million out of which 832.50 million shares are floated in the stock market.
Universal Detection Technology takes pride as on of the biggest supplier of Anthrax detection kits to US Army. Headquartered in Beverly Hills, California, the company was incorporated in 1971 and was previously registered in the name of Pollution Research and Control Corporation.
(OTC:UNDT) takes pride in its main brand BSM-2000 device, which functions as an automated bacterial spore detector. The device especially detects airborne endospores in public places such as anthrax. Other than anthrax detection kits UNDT offers long range of its product portfolio including radiation detection systems, surveillance cameras, training material and reference DVDs.
Universal Detection Technology (OTC:UNDT has recently entered into partnership with Morphix Technologies Inc. Morphix Technologies specializes in detection tools for dangerous industrial chemicals and chemical weapons. As Morphix Technologies takes pride in its innovative product of chemical detection branded as Chameleon developed specially for first responders, it is believed that both companies can achieve a lot together in product development and can also further penetrate other market segments too.
That’s not it UNDT itself going on fast track as far development is concerned. Almost two weeks ago UNDT also addressed the dire need of Anthrax vaccination for first responders in all the respective agencies like fire team, bomb squad and etc. It is also believed that Universal Detection products and kits are most used by first responders because of their quality and effectiveness.
The company’s total assets stand around $0.14 million and maintains current portion of long term liabilities around $1.22 million as on financial statements ending September 30th, 2009. It is hoped that the total debt would be nil by the next year if the company does not opt for anymore long term financing within the period.
You may be right about the day traders rally. I am going to stick to my plan and buy on the dips building and adding to my shares. They have contracts from several goverments and the expanding product lines should help for future agreements.I still look at this one as long term. Somewhat risky I know but time will tell. On the dips, buy, buy, buy. Good luck to all.
flafly,
The numbers are not expected to look good. I am not looking at the past on this one now. The partnership reduces the limitations. I am looking at the future. And the long trem is so bright I gotta wear shades.
OK everyone. Better buckle up your seat belts and hold on for a wild ride this week on UNDT. There may be lots of ups and downs. I am looking to buy on the dips and hold this one long term with a large position.